Search research articles
Contact Us
Filters
Showing results (11-20 of 111) with videos related to
Page
of 12
Sort By:
British Journal of Haematology
|
April 14, 2016
Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patients
Raynier Devillier, Angela Granata, Sabine Fürst, et al.
Cancer
|
October 20, 2010
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study
Thomas Prebet, Anne Etienne, Raynier Devillier, et al.
Cancer Chemotherapy and Pharmacology
|
November 13, 2023
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Mourad Hamimed, Raynier Devillier, Pierre-Jean Weiller, et al.
Frontiers in Medicine
|
April 17, 2023
Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysis
Wen-Hui Gao, Jia-Yan Zhu, Li-Ning Wang, et al.
Hematological Oncology
|
December 5, 2013
Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma
Sylvain Garciaz, Diane Coso, Frederic Peyrade, et al.
Bone Marrow Transplantation
|
August 8, 2018
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes
Ling Wang, Raynier Devillier, Ming Wan, et al.
American Journal of Hematology
|
January 31, 2017
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimen
Aude Collignon, Boris Calmels, Samia Harbi, et al.
BMC Cancer
|
August 7, 2014
Constitutive AKT activation in follicular lymphoma
Ouardia I Yahiaoui, Jacques A Nunès, Céline Castanier, et al.
American Journal of Hematology
|
September 16, 2014
Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients
Raynier Devillier, Véronique Gelsi-Boyer, Anne Murati, et al.
Cancers
|
June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor
Raynier Devillier, Boris Calmels, Sophie Guia, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 111) with videos related to
Sort By:
Page
of 12
British Journal of Haematology
|
April 14, 2016
Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patients
Raynier Devillier, Angela Granata, Sabine Fürst, et al.
Cancer
|
October 20, 2010
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study
Thomas Prebet, Anne Etienne, Raynier Devillier, et al.
Cancer Chemotherapy and Pharmacology
|
November 13, 2023
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Mourad Hamimed, Raynier Devillier, Pierre-Jean Weiller, et al.
Frontiers in Medicine
|
April 17, 2023
Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysis
Wen-Hui Gao, Jia-Yan Zhu, Li-Ning Wang, et al.
Hematological Oncology
|
December 5, 2013
Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma
Sylvain Garciaz, Diane Coso, Frederic Peyrade, et al.
Bone Marrow Transplantation
|
August 8, 2018
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes
Ling Wang, Raynier Devillier, Ming Wan, et al.
American Journal of Hematology
|
January 31, 2017
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimen
Aude Collignon, Boris Calmels, Samia Harbi, et al.
BMC Cancer
|
August 7, 2014
Constitutive AKT activation in follicular lymphoma
Ouardia I Yahiaoui, Jacques A Nunès, Céline Castanier, et al.
American Journal of Hematology
|
September 16, 2014
Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients
Raynier Devillier, Véronique Gelsi-Boyer, Anne Murati, et al.
Cancers
|
June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor
Raynier Devillier, Boris Calmels, Sophie Guia, et al.
Page
of 12